Epigenomics Request Triggers CMS Plan To Cover Colorectal Cancer Blood-Based Biomarker Tests

The US Centers for Medicare and Medicaid Services is considering a national coverage determination for a blood-based biomarker screening test for colorectal cancer after receiving a request for a national coverage determination from Epigenomics for its Epi proColon assay.